Doxorubicin, cyclophosphamide in childhood increases risk for second malignancies
- OPACC
- Jun 16, 2017
- 1 min read
Patients who received doxorubicin for childhood cancers faced an increased risk for breast cancer and solid tumors later in life, according to researchers in the Netherlands.
Comments